HAEMATO : proposes dividend payment

DGAP-Ad-hoc: HAEMATO AG / Key word(s): Dividend/Payout HAEMATO AG proposes dividend payment 04-May-2021 / 15:10 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Ad hoc of HAEMATO AG: HAEMATO AG proposes dividend payment The Supervisory Board of HAEMATO AG approved the Executive Board's proposal for the appropriation of profits at today's balance sheet meeting. The Executive Board and Supervisory Board will therefore propose a dividend of EUR 1.00 per dividend-bearing share at the Annual General Meeting to be held on July 13, 2021. About HAEMATO: HAEMATO AG, founded in 1993, is a pharmaceutical company. The focus of its business activities is on the trading of high-priced special pharmaceuticals (with a therapeutic focus on cancer, HIV and other chronic diseases) as well as the development and distribution of medical products and own brands, particularly in the field of "aesthetic medicine". HAEMATO AG is listed on the Basic Board (Open Market) of the Frankfurt Stock Exchange. Key figures of the HAEMATO AG share: Subscribed capital: EUR 5,299,307 Listed share class: Ordinary bearer shares ISIN: DE000A289VV1 WKN: A289VV Stock exchange symbol: HAEK Contact: HAEMATO AG, Investor Relations Telefon: [phone] [e-mail] 04-May-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	HAEMATO AG
	Lilienthalstraße 5c
	12529 Schönefeld
	Germany
Phone:	[phone]
Fax:	[phone]
E-mail:	[e-mail]
Internet:	www.haemato.ag
ISIN:	DE000A289VV1
WKN:	A289VV
Listed:	Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Hamburg, Stuttgart, Tradegate Exchange
EQS News ID:	1192406

End of Announcement	DGAP News Service

1192406  04-May-2021 CET/CEST